Senior Vice President and Chief Accounting Officer · National Health Investors Inc. (NHI)

David Travis

A named executive officer of National Health Investors in every fiscal year CompBrief holds from FY2022 to FY2025. Every figure below is printed as the company filed it and cited to the filing it came from.

Velarion Intel: free for 3 days, no card →

Total disclosed compensation, FY2025

$1,438,600

FY2024: $970,643

4th of 5 named executive officers at National Health Investors by FY2025 total.

5 named officers on file for National Health Investors, FY2025

See an example →

What this number hides

The filing gives the total. National Health Investors’s full Executive Compensation Report gives every award, the disclosed peer set and what the total leaves out — the pair adds the board’s.

Velarion Intel · free for 3 days · no card

See how National Health Investors’s whole pay program stands against its peers

  • National Health Investors’s company dashboard and its AI-written, board-ready brief, every figure cited to the filing
  • Peer-group intelligence, custom peer reruns and governance screens
  • Every other company we cover, with alerts when they file
Start my free trial on NHI→

No card. Nothing is charged, and the trial ends on its own.

Compensation figures as of the proxy filed April 3, 2026 (DEF 14A). Insider transactions since that proxy, current to 2026-11-10.

Free

Get David Travis’s full pay file as a PDF — free

More than this page: up to 10 years of David’s pay history, a side-by-side peer comparison, and a one-page board summary — the whole file, yours now and by email.

Also free: The Pay Desk, the weekly executive pay briefing.

Or track David Travis and every company like it: Velarion Intel, free for 3 days, no card →

David Travis compensation by year

National Health Investors Summary Compensation Table · all 4 fiscal years held
In US dollars, as National Health Investors reports it. Most recent year shaded. Totals are the company’s disclosed totals.
ComponentFY2022FY2023FY2024FY2025
Salary$275,000$300,000$315,000$330,000
Bonus$200,000$23,829$0$0
Stock awards$0$197,200$173,280$403,370
Option awards$408,268$283,203$197,013$282,230
Non-equity incentive$0$201,171$275,000$412,500
Pension and deferred compensation$0$0$0—
All other$9,150$9,900$10,350$10,500
Total$892,418$1,015,303$970,643$1,438,600

Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: National Health Investors Inc. DEF 14A filed April 3, 2026, accession 0000877860-26-000098, and prior-year filings. Open the filing on EDGAR.

How this page was built: the National Health Investors Inc. filed document, accession 0000877860-26-000098. Every figure is read from that document and cited to the page and table it appears in. Filed April 3, 2026.

$892K
$1.0M
$971K
$1.4M
FY22
FY23
FY24
FY25
SalaryBonusNon-equity incentiveStock awardsOption awardsAll other

Equity holdings

unvested awards at FY2025 year-end
TypeUnvested unitsValue at year-endExercise price
RSU10,300$786,611—
Option20,000—$73.34
Option8,334—$57.76

Per the Outstanding Equity Awards at Fiscal Year-End table in National Health Investors Inc.'s FY2025 proxy; value at the fiscal year-end close, as the company printed it.

Insider transactions since the last proxy

1 Form 4 line since the FY2025 proxy (filed April 3, 2026)
current to 2026-11-10 · updated nightly
DateTransactionPlanSharesPriceHeld after
2026-05-05Tax withholding—282$73.0940,565

The 1 most recent of 1 lines, each as reported on the Form 4. "10b5-1" marks a trade the filing reports under a pre-arranged trading plan. View every Form 4 filing on EDGAR →

National Health Investors’s named executive officers, FY2025

as the company reported each
Named executive officerRoleFY2025 total
D. Eric MendelsohnPresident and CEO$3,652,795
John SpaidExecutive Vice President of Finance, Chief Financial Officer and Treasurer$2,180,555
Kevin PascoeExecutive Vice President of Investments and Chief Investment Officer$1,987,215
David Travis · this pageSenior Vice President and Chief Accounting Officer$1,438,600
Kristin GainesSenior Vice President and Chief Transaction Officer$1,326,552

David Travis's compensation dossier, National Health Investors

You have read David Travis's totals and holdings. The dossier adds each equity grant National Health Investors disclosed for David Travis and National Health Investors's own disclosed peer group, where the company discloses them, with every row in a PDF and a CSV cited to its filing.

See an example →

The full National Health Investors compensation record

free company brief

This page is one person within National Health Investors's record. The company brief lists every named executive, each linking to their own page.

Peer companies

named in the National Health Investors proxy · each links to its own free brief

Compensation, the day it’s disclosed

The CompBrief Daily Digest lists the newest executive and director compensation disclosures as companies file them. Or order National Health Investors's full Executive Compensation Report with peer benchmarking.

How this record is built

Every figure on this page is one figure from a public SEC filing, printed as the filing states it and cited to the document. Compensation totals are National Health Investors's own disclosed totals, not summed by Velarion. Insider transactions are read from Form 4 filings and cover every line filed since the most recent proxy. Nothing is estimated by Velarion; where the company does not disclose a value the cell reads "—", and a section appears only where the company discloses the data. Corrections: records@velarion.ai.

Order NHI

Add the email the receipt and the PDF go to, then press the report you want. Each button opens its own card payment on Stripe.

Receipt, invoice, and report delivery. Guest checkout, no account required, secure payment by Stripe.

David Travis's compensation dossier